38532783|t|Cinnamic acid, a natural plant compound, exhibits neuroprotection in a mouse model of Sandhoff disease via PPARalpha.
38532783|a|Tay-Sachs disease (TSD) and its severe form Sandhoff disease (SD) are autosomal recessive lysosomal storage metabolic disorders, which often result into excessive GM2 ganglioside accumulation predominantly in lysosomes of nerve cells. Although patients with these diseases appear normal at birth, the progressive accumulation of undegraded GM2 gangliosides in neurons leads to early death accompanied by manifestation of motor difficulties and gradual loss of behavioral skills. Unfortunately, there is still no effective treatment available for TSD/SD. The present study highlights the importance of cinnamic acid (CA), a naturally occurring aromatic fatty acid present in a number of plants, in inhibiting the disease process in a transgenic mouse model of SD. Oral administration of CA significantly attenuated glial activation and inflammation and reduced the accumulation of GM2 gangliosides/glycoconjugates in the cerebral cortex of Sandhoff mice. Besides, oral CA also improved behavioral performance and increased the survival of Sandhoff mice. While assessing the mechanism, we found that oral administration of CA increased the level of peroxisome proliferator-activated receptor alpha (PPARalpha) in the brain of Sandhoff mice and that oral CA remained unable to reduce glycoconjugates, improve behavior and increase survival in Sandhoff mice lacking PPARalpha. Our results indicate a beneficial function of CA that utilizes a PPARalpha-dependent mechanism to halt the progression of SD and thereby increase the longevity of Sandhoff mice.
38532783	0	13	Cinnamic acid	Chemical	MESH:C029010
38532783	71	76	mouse	Species	10090
38532783	86	102	Sandhoff disease	Disease	MESH:D012497
38532783	107	116	PPARalpha	Gene	19013
38532783	118	135	Tay-Sachs disease	Disease	MESH:D013661
38532783	137	140	TSD	Disease	MESH:D013661
38532783	162	178	Sandhoff disease	Disease	MESH:D012497
38532783	180	182	SD	Disease	MESH:D012497
38532783	188	245	autosomal recessive lysosomal storage metabolic disorders	Disease	MESH:D016464
38532783	281	296	GM2 ganglioside	Chemical	MESH:D005678
38532783	362	370	patients	Species	9606
38532783	458	474	GM2 gangliosides	Chemical	MESH:D005678
38532783	501	506	death	Disease	MESH:D003643
38532783	539	557	motor difficulties	Disease	MESH:D051346
38532783	664	667	TSD	Disease	MESH:D013661
38532783	668	670	SD	Disease	MESH:D012497
38532783	719	732	cinnamic acid	Chemical	MESH:C029010
38532783	734	736	CA	Chemical	MESH:C029010
38532783	761	780	aromatic fatty acid	Chemical	-
38532783	862	867	mouse	Species	10090
38532783	877	879	SD	Disease	MESH:D012497
38532783	904	906	CA	Chemical	MESH:C029010
38532783	953	965	inflammation	Disease	MESH:D007249
38532783	998	1014	GM2 gangliosides	Chemical	MESH:D005678
38532783	1066	1070	mice	Species	10090
38532783	1086	1088	CA	Chemical	MESH:C029010
38532783	1165	1169	mice	Species	10090
38532783	1239	1241	CA	Chemical	MESH:C029010
38532783	1265	1313	peroxisome proliferator-activated receptor alpha	Gene	19013
38532783	1315	1324	PPARalpha	Gene	19013
38532783	1351	1355	mice	Species	10090
38532783	1370	1372	CA	Chemical	MESH:C029010
38532783	1467	1471	mice	Species	10090
38532783	1480	1489	PPARalpha	Gene	19013
38532783	1537	1539	CA	Chemical	MESH:C029010
38532783	1556	1565	PPARalpha	Gene	19013
38532783	1613	1615	SD	Disease	MESH:D012497
38532783	1663	1667	mice	Species	10090
38532783	Positive_Correlation	MESH:C029010	19013
38532783	Negative_Correlation	MESH:C029010	MESH:D005678
38532783	Negative_Correlation	MESH:C029010	MESH:D013661
38532783	Negative_Correlation	MESH:C029010	MESH:D007249
38532783	Positive_Correlation	MESH:D005678	MESH:D051346
38532783	Positive_Correlation	MESH:D005678	MESH:D003643
38532783	Positive_Correlation	MESH:D005678	MESH:D013661
38532783	Association	MESH:D012497	19013
38532783	Negative_Correlation	MESH:C029010	MESH:D012497

